Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

James Miller

Concepts (326)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
44
2020
2221
2.910
Why?
Smoking
20
2019
1457
1.350
Why?
Bronchi
13
2018
241
1.310
Why?
Carcinoma in Situ
5
2019
43
1.190
Why?
Carcinogens
4
2012
106
0.820
Why?
Carcinoma, Squamous Cell
10
2018
610
0.810
Why?
Chemoprevention
3
2019
88
0.780
Why?
Vascular Endothelial Growth Factor Receptor-2
2
2012
86
0.770
Why?
Lung
16
2020
3588
0.670
Why?
Carcinoma, Small Cell
7
2008
158
0.540
Why?
Bronchopulmonary Dysplasia
2
2019
328
0.520
Why?
Urethane
3
2012
41
0.520
Why?
Bronchoscopy
9
2019
244
0.500
Why?
Sputum
8
2019
289
0.500
Why?
Pulmonary Alveoli
4
2012
373
0.490
Why?
Iloprost
2
2012
46
0.490
Why?
Hyperplasia
7
2011
169
0.490
Why?
Precancerous Conditions
7
2020
156
0.470
Why?
Neprilysin
3
1998
47
0.450
Why?
Biomarkers, Tumor
7
2015
1053
0.440
Why?
Piperidines
2
2012
168
0.430
Why?
Quinazolines
2
2012
244
0.420
Why?
Antineoplastic Agents
4
2013
1941
0.420
Why?
Biopsy
11
2019
1056
0.410
Why?
DNA Copy Number Variations
1
2011
158
0.370
Why?
Bombesin
5
1998
14
0.370
Why?
Genetic Markers
1
2011
338
0.370
Why?
Amidohydrolases
3
1998
29
0.350
Why?
Carcinoma, Non-Small-Cell Lung
7
2013
974
0.350
Why?
Neurosecretory Systems
4
2004
32
0.340
Why?
Tocopherols
1
2009
20
0.340
Why?
Isotretinoin
1
2009
22
0.340
Why?
Ki-67 Antigen
3
2015
105
0.340
Why?
Vasodilator Agents
1
2011
311
0.340
Why?
Mass Screening
3
2008
1034
0.340
Why?
ErbB Receptors
1
2012
569
0.330
Why?
Membrane Proteins
2
2008
1040
0.320
Why?
Neovascularization, Pathologic
6
2015
286
0.310
Why?
Pulmonary Disease, Chronic Obstructive
4
2018
1114
0.290
Why?
Respiratory Mucosa
2
2008
253
0.290
Why?
Adenocarcinoma
6
2012
793
0.270
Why?
Hypoxia
1
2012
950
0.270
Why?
Middle Aged
28
2019
27170
0.240
Why?
Chromosomes, Human, Pair 3
4
2000
50
0.240
Why?
Aged
25
2019
19356
0.240
Why?
Chromosome Aberrations
4
2013
135
0.230
Why?
Carcinoma, Bronchogenic
2
2002
17
0.230
Why?
Tomography, Spiral Computed
1
2002
24
0.220
Why?
Humans
53
2020
117047
0.210
Why?
Female
33
2019
60630
0.210
Why?
Sensitivity and Specificity
10
2010
1740
0.200
Why?
Double-Blind Method
2
2019
1670
0.200
Why?
Smokers
2
2019
148
0.200
Why?
Lung Diseases
5
2015
693
0.190
Why?
Placebos
2
2019
198
0.190
Why?
Small Cell Lung Carcinoma
2
2012
83
0.190
Why?
Male
30
2019
56660
0.190
Why?
Tomography, X-Ray Computed
2
2020
2403
0.190
Why?
Tumor Cells, Cultured
6
1998
860
0.170
Why?
Neuropeptides
4
1998
66
0.170
Why?
Radiographic Image Interpretation, Computer-Assisted
1
2020
108
0.170
Why?
Remission Induction
1
2019
243
0.160
Why?
Peptides
3
1996
868
0.160
Why?
In Situ Hybridization, Fluorescence
6
2010
310
0.160
Why?
Blotting, Western
4
2012
1172
0.150
Why?
Lung Diseases, Obstructive
1
1997
40
0.150
Why?
Genes, p53
1
1997
64
0.150
Why?
Antibodies, Monoclonal
3
2010
1271
0.150
Why?
Proteomics
2
2015
844
0.150
Why?
Point Mutation
1
1997
225
0.140
Why?
Immunohistochemistry
8
2015
1657
0.140
Why?
Radiation Injuries, Experimental
1
1996
24
0.140
Why?
Bradykinin
1
1996
46
0.130
Why?
Mice
10
2012
15308
0.130
Why?
Endopeptidases
1
1996
71
0.130
Why?
Chromosomal Instability
2
2013
18
0.130
Why?
Animals
13
2013
32736
0.130
Why?
Smoking Cessation
1
2019
357
0.130
Why?
Hyperoxia
1
1996
93
0.130
Why?
Multiple Pulmonary Nodules
1
2015
26
0.120
Why?
Risk Factors
5
2019
8873
0.120
Why?
Aged, 80 and over
8
2015
6453
0.120
Why?
Antigens
1
1996
319
0.120
Why?
Methylcholanthrene
2
2012
18
0.120
Why?
Gene Expression
3
1998
1466
0.120
Why?
Mice, Transgenic
5
2009
1993
0.120
Why?
Butylated Hydroxytoluene
2
2012
32
0.120
Why?
Mutation
4
2000
3420
0.120
Why?
Algorithms
3
2020
1505
0.120
Why?
Microarray Analysis
1
2013
119
0.110
Why?
Stem Cells
1
2018
547
0.110
Why?
Epithelium
4
2018
302
0.110
Why?
Intramolecular Oxidoreductases
2
2004
58
0.110
Why?
Epithelial Cells
3
2007
940
0.110
Why?
Biological Products
1
1996
176
0.110
Why?
Carcinoma, Large Cell
1
2012
14
0.110
Why?
Cytochrome P-450 Enzyme System
2
2004
110
0.110
Why?
Risk
5
2012
842
0.110
Why?
Receptors, Bombesin
1
2012
3
0.100
Why?
Bronchoalveolar Lavage Fluid
3
2002
600
0.100
Why?
Case-Control Studies
8
2012
3099
0.100
Why?
Volatile Organic Compounds
1
2012
58
0.100
Why?
Immunoenzyme Techniques
1
2012
194
0.100
Why?
Cell Division
4
2000
767
0.100
Why?
Veterans
1
2002
1231
0.100
Why?
Sleep Apnea Syndromes
1
2012
80
0.100
Why?
Proto-Oncogene Proteins c-myc
1
2012
115
0.100
Why?
Dose-Response Relationship, Drug
2
2010
1889
0.100
Why?
Chromosomes, Human, Pair 15
1
2011
53
0.100
Why?
Eosinophilic Granuloma
1
1990
3
0.090
Why?
Epithelial-Mesenchymal Transition
1
2012
171
0.090
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2012
219
0.090
Why?
Adult
16
2018
31003
0.090
Why?
Predictive Value of Tests
4
2009
1824
0.090
Why?
Antioxidants
2
2012
554
0.090
Why?
Disease Progression
5
2018
2467
0.090
Why?
Calcium
1
1996
1125
0.090
Why?
Proteins
1
1996
930
0.090
Why?
Cell Line
5
2013
2670
0.090
Why?
Plants, Toxic
1
1989
28
0.090
Why?
Somatomedins
1
2009
27
0.090
Why?
Genome-Wide Association Study
2
2013
1314
0.090
Why?
Cell Proliferation
2
2018
2236
0.090
Why?
Intracellular Signaling Peptides and Proteins
2
2011
399
0.090
Why?
Chromosome Deletion
1
1989
94
0.080
Why?
Bronchial Neoplasms
1
2009
14
0.080
Why?
Neoplasms, Glandular and Epithelial
1
2009
40
0.080
Why?
Neoplasm Invasiveness
4
2015
453
0.080
Why?
GPI-Linked Proteins
1
2008
56
0.080
Why?
Respiratory System
1
1989
141
0.080
Why?
Airway Obstruction
3
2009
165
0.080
Why?
Fluorescence
3
2009
157
0.080
Why?
Inflammation
1
2018
2515
0.080
Why?
Alkaline Phosphatase
1
2008
152
0.080
Why?
Spectral Karyotyping
1
2007
5
0.080
Why?
Polymorphism, Genetic
1
2011
629
0.080
Why?
Fibroblasts
3
1998
839
0.070
Why?
Molecular Targeted Therapy
1
2010
354
0.070
Why?
Isoenzymes
1
2008
293
0.070
Why?
Proto-Oncogene Proteins p21(ras)
1
2008
232
0.070
Why?
Cell Transformation, Neoplastic
1
2009
311
0.070
Why?
Pulmonary Surfactants
2
1999
98
0.070
Why?
Exons
2
1998
302
0.070
Why?
Molecular Sequence Data
5
1998
2817
0.070
Why?
Early Detection of Cancer
1
2010
356
0.070
Why?
Follow-Up Studies
2
2015
4507
0.070
Why?
MicroRNAs
1
2012
627
0.070
Why?
Biomarkers
3
2010
3549
0.070
Why?
Polymorphism, Single Nucleotide
1
2013
2038
0.070
Why?
ROC Curve
3
2015
460
0.070
Why?
Enzyme-Linked Immunosorbent Assay
3
2005
798
0.070
Why?
Adaptor Proteins, Signal Transducing
1
2008
391
0.060
Why?
Recombinant Proteins
3
1998
1258
0.060
Why?
RNA, Messenger
3
1998
2632
0.060
Why?
Polymerase Chain Reaction
3
1998
1001
0.060
Why?
Protein Kinase Inhibitors
1
2010
803
0.060
Why?
Growth Hormone-Releasing Hormone
1
2004
27
0.060
Why?
Cytokines
1
2012
1852
0.060
Why?
Acromegaly
1
2004
15
0.060
Why?
Rats
4
2004
5172
0.060
Why?
Neoplasm Recurrence, Local
1
2009
878
0.060
Why?
Adrenocorticotropic Hormone
1
2004
151
0.060
Why?
Cross-Sectional Studies
2
2018
4510
0.060
Why?
Smoke
1
2004
135
0.050
Why?
Base Sequence
3
1998
2123
0.050
Why?
Solitary Pulmonary Nodule
1
2002
25
0.050
Why?
Metaplasia
2
2018
56
0.050
Why?
Pulmonary Fibrosis
2
1998
304
0.050
Why?
Vascular Endothelial Growth Factor A
1
2005
512
0.050
Why?
Sex Factors
1
2007
1758
0.050
Why?
Radiation Dosage
1
2002
143
0.050
Why?
Hospitals, Veterans
1
2002
239
0.050
Why?
Reproducibility of Results
1
2008
2818
0.050
Why?
Cohort Studies
4
2015
5050
0.040
Why?
Gene Expression Regulation
1
1989
2408
0.040
Why?
Feasibility Studies
1
2002
750
0.040
Why?
Amino Acid Sequence
3
1994
2032
0.040
Why?
Gastrin-Releasing Peptide
2
1996
6
0.040
Why?
Signal Transduction
3
1998
4606
0.040
Why?
Light
1
2001
335
0.040
Why?
Autocrine Communication
1
1998
42
0.040
Why?
gamma Catenin
1
2018
17
0.040
Why?
Desmoglein 3
1
2018
17
0.040
Why?
Loss of Heterozygosity
2
2013
40
0.040
Why?
Paracrine Communication
1
1998
55
0.040
Why?
Bronchial Diseases
1
2018
34
0.040
Why?
DNA Primers
2
1998
525
0.040
Why?
Up-Regulation
2
2005
837
0.040
Why?
Gene Expression Profiling
1
2005
1588
0.040
Why?
Neoplasm Transplantation
1
1998
242
0.040
Why?
Cell Cycle Checkpoints
1
2018
85
0.040
Why?
Time
1
2018
75
0.040
Why?
Vascular Cell Adhesion Molecule-1
1
1998
37
0.040
Why?
Telangiectasia, Hereditary Hemorrhagic
1
1998
10
0.040
Why?
United States
2
2011
12379
0.040
Why?
Polymorphism, Single-Stranded Conformational
1
1997
28
0.040
Why?
Genes, Tumor Suppressor
1
1998
76
0.040
Why?
Alveolitis, Extrinsic Allergic
1
1998
84
0.040
Why?
Likelihood Functions
1
1998
134
0.040
Why?
Polymorphism, Restriction Fragment Length
1
1997
64
0.040
Why?
Neoplasm Staging
2
2012
1206
0.040
Why?
DNA, Complementary
1
1998
263
0.040
Why?
Codon
1
1997
84
0.040
Why?
Gene Expression Regulation, Enzymologic
1
1998
280
0.040
Why?
Introns
1
1998
228
0.040
Why?
Treatment Outcome
1
2011
9256
0.040
Why?
Membrane Glycoproteins
1
1999
439
0.040
Why?
Mice, Nude
1
1998
653
0.040
Why?
Incidence
3
2010
2377
0.040
Why?
Machine Learning
1
2020
315
0.040
Why?
Immunoassay
2
1998
99
0.030
Why?
Enzyme Activation
1
1998
793
0.030
Why?
RNA, Neoplasm
1
1996
76
0.030
Why?
Image Processing, Computer-Assisted
1
2020
696
0.030
Why?
Mesothelioma
1
1996
31
0.030
Why?
Glycopeptides
1
1996
58
0.030
Why?
Antigens, CD
2
1998
450
0.030
Why?
Databases, Factual
1
2020
1167
0.030
Why?
Sequence Analysis, DNA
1
1998
741
0.030
Why?
Proto-Oncogene Proteins
1
2018
615
0.030
Why?
Myelin Sheath
1
1996
146
0.030
Why?
Cell Cycle Proteins
1
2018
563
0.030
Why?
Prospective Studies
3
2012
6389
0.030
Why?
Receptors, Peptide
1
1994
18
0.030
Why?
Rh-Hr Blood-Group System
1
1994
11
0.030
Why?
Liver Neoplasms
1
1998
523
0.030
Why?
Neoplasm Metastasis
1
1996
534
0.030
Why?
Blotting, Southern
1
1993
66
0.030
Why?
Erythrocyte Membrane
1
1994
53
0.030
Why?
Blotting, Northern
1
1993
190
0.030
Why?
Endoscopy
1
2015
266
0.030
Why?
DNA, Neoplasm
1
1993
151
0.030
Why?
Solid Phase Microextraction
1
2012
8
0.030
Why?
Colorado
1
2002
4120
0.030
Why?
Cells, Cultured
2
2007
3956
0.030
Why?
Gene Expression Regulation, Neoplastic
1
2018
1158
0.030
Why?
Dinoprostone
2
2004
191
0.030
Why?
Fluorescent Antibody Technique
1
1993
400
0.030
Why?
Breath Tests
1
2012
88
0.030
Why?
Enzyme Inhibitors
1
1996
775
0.030
Why?
Gas Chromatography-Mass Spectrometry
1
2012
129
0.030
Why?
Cloning, Molecular
1
1993
524
0.030
Why?
Iceland
1
2011
6
0.020
Why?
Tumor Suppressor p53-Binding Protein 1
1
2011
12
0.020
Why?
Spain
1
2011
34
0.020
Why?
Respiratory Tract Diseases
1
1992
141
0.020
Why?
Netherlands
1
2011
65
0.020
Why?
Rats, Sprague-Dawley
1
1996
2321
0.020
Why?
Cattle
1
1993
957
0.020
Why?
Administration, Oral
1
2012
744
0.020
Why?
Severity of Illness Index
1
2018
2633
0.020
Why?
Meta-Analysis as Topic
1
2011
165
0.020
Why?
Prognosis
2
2012
3390
0.020
Why?
Flow Cytometry
1
1993
1063
0.020
Why?
Carrier Proteins
1
1994
719
0.020
Why?
Receptor, IGF Type 1
1
2009
59
0.020
Why?
Area Under Curve
1
2010
285
0.020
Why?
Cystic Fibrosis
1
1998
977
0.020
Why?
International Agencies
1
2009
29
0.020
Why?
Erythrocytes
1
1994
604
0.020
Why?
Pilot Projects
1
2012
1394
0.020
Why?
Chromatography, High Pressure Liquid
1
1989
475
0.020
Why?
Mass Spectrometry
1
2010
661
0.020
Why?
Genome, Human
1
2009
377
0.020
Why?
Models, Statistical
1
2010
627
0.020
Why?
Disease Models, Animal
1
1996
3648
0.020
Why?
Amino Acids
1
1989
460
0.020
Why?
Genotype
1
2011
1854
0.020
Why?
Receptors, Vascular Endothelial Growth Factor
1
2005
102
0.020
Why?
Genomics
1
2009
658
0.020
Why?
Epoprostenol
1
2004
132
0.010
Why?
Bronchiolitis
1
2004
82
0.010
Why?
Autoantibodies
1
2010
1332
0.010
Why?
Pituitary Neoplasms
1
2004
161
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
965
0.010
Why?
Vegetables
1
2003
131
0.010
Why?
Fruit
1
2003
129
0.010
Why?
Respiratory Function Tests
1
2004
523
0.010
Why?
Adenoma
1
2004
190
0.010
Why?
Genetic Predisposition to Disease
1
2011
2227
0.010
Why?
Oligonucleotide Array Sequence Analysis
1
2004
761
0.010
Why?
Weight Gain
1
2004
481
0.010
Why?
Regression Analysis
1
2003
971
0.010
Why?
Single-Blind Method
1
2001
259
0.010
Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2000
54
0.010
Why?
Carcinoma
1
2001
201
0.010
Why?
RNA
1
2005
827
0.010
Why?
Bronchoscopes
1
1998
5
0.010
Why?
Retrospective Studies
1
2015
12823
0.010
Why?
Endoglin
1
1998
20
0.010
Why?
Random Allocation
1
1998
339
0.010
Why?
Reference Values
1
1998
750
0.010
Why?
Genetic Linkage
1
1998
311
0.010
Why?
Longitudinal Studies
1
2003
2480
0.010
Why?
Comorbidity
1
2001
1487
0.010
Why?
Tumor Suppressor Protein p53
1
2000
450
0.010
Why?
Diet
1
2003
1128
0.010
Why?
Linear Models
1
1998
802
0.010
Why?
Receptors, Cell Surface
1
1998
355
0.010
Why?
Analysis of Variance
1
1998
1239
0.010
Why?
Young Adult
1
2011
10674
0.010
Why?
Alleles
1
1998
816
0.010
Why?
Infant, Premature
1
1998
478
0.010
Why?
Risk Assessment
1
2004
3021
0.010
Why?
CD47 Antigen
1
1994
22
0.010
Why?
Chromatography, Affinity
1
1994
84
0.010
Why?
Endothelium, Vascular
1
2000
860
0.010
Why?
Moths
1
1994
36
0.010
Why?
Genes
1
1994
221
0.010
Why?
Electrophoresis, Polyacrylamide Gel
1
1994
322
0.010
Why?
Cytoplasm
1
1994
269
0.010
Why?
Chromosome Mapping
1
1994
498
0.010
Why?
Carcinoid Tumor
1
1992
25
0.010
Why?
Adolescent
1
2011
18213
0.010
Why?
Lymphocytes
1
1994
340
0.010
Why?
Transfection
1
1994
877
0.010
Why?
Dyspnea
1
1992
202
0.010
Why?
Mice, Inbred BALB C
1
1994
1183
0.010
Why?
Binding Sites
1
1994
1206
0.010
Why?
Fibrosis
1
1992
478
0.010
Why?
Phenotype
1
1998
2891
0.010
Why?
Aging
1
1998
1653
0.010
Why?
Infant, Newborn
1
1998
5170
0.000
Why?
Infant
1
1998
8121
0.000
Why?
Child, Preschool
1
1998
9322
0.000
Why?
Child
1
1998
18876
0.000
Why?
Miller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)